Table 2.
Participant characteristics in all cohort x group conditions, as well as overall
| Innovation Lab | TAU Control | Grand Total | |||||
|---|---|---|---|---|---|---|---|
| Cohort 1abc | Cohort 2bd | Total | Cohort 1 | Cohort 2 e | Total | ||
| N randomized | 24 | 23 | 47 | 24 | 24 | 48 | 95 |
| Sex, % female | 73.9% | 69.6% | 71.7% | 75.0% | 78.3% | 76.6% | 74.2% |
| Race | |||||||
| African/AA | 0.0% | 4.5% | 2.2% | 0.0% | 4.3% | 2.1% | 2.2% |
| Asian | 8.7% | 13.6% | 11.1% | 12.5% | 13.0% | 12.8% | 12.0% |
| White | 82.6% | 77.3% | 80.0% | 87.5% | 78.3% | 83.0% | 81.5% |
| Multiple/Other | 8.7% | 4.5% | 6.7% | 0.0% | 4.3% | 2.1% | 4.3% |
| Ethnicity, Hispanic | 0.0% | 13.6% | 6.5% | 0.0% | 13.0% | 6.4% | 6.5% |
| Age, mean (SD) | 37.7 (4.8) | 38.9 (6.3) | 38.3 (5.6) | 37.1 (5.8) | 38.3 (6.7) | 37.7 (6.2) | 38.0 (5.9) |
| Terminal degree | |||||||
| MD | 33.3% | 13.0% | 23.4% | 29.2% | 13.0% | 21.3% | 22.3% |
| PhD | 58.3% | 82.6% | 70.2% | 54.2% | 82.6% | 68.1% | 69.1% |
| MD-PhD | 4.2% | 4.3% | 4.3% | 12.5% | 4.3% | 8.5% | 6.4% |
| Other | 4.2% | 0.0% | 2.1% | 4.2% | 0.0% | 2.1% | 2.1% |
a
One participant did not disclose their sex.
b
One participant did not disclose their race.
c
One participant did not disclose their age.
d
One participant did not disclose their ethnicity.
e
Though 24 ppts were randomized to control, one ppt withdrew at end of treatment and asked that all their data be deleted. Therefore, the table provides information based on the remaining 23 participants.